Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 311 (7012), 1047-52

Anticonvulsant Drugs for Management of Pain: A Systematic Review

Affiliations
Review

Anticonvulsant Drugs for Management of Pain: A Systematic Review

H McQuay et al. BMJ.

Abstract

Objective: To determine effectiveness and adverse effects of anticonvulsant drugs in management of pain.

Design: Systematic review of randomised controlled trials of anticonvulsants for acute, chronic, or cancer pain identified by using Medline, by hand searching, by searching reference lists, and by contacting investigators.

Subjects: Between 1966 and February 1994, 37 reports were found; 20 reports, of four anticonvulsants, were eligible.

Main outcome measures: Numbers needed to treat were calculated for effectiveness, adverse effects, and drug related withdrawal from study.

Results: The only placebo controlled study in acute pain found no analgesic effect of sodium valproate. For treating trigeminal neuralgia, carbamazepine had a combined number needed to treat of 2.6 for effectiveness, 3.4 for adverse effects, and 24 for severe effects (withdrawal from study). For treating diabetic neuropathy, anticonvulsants had a combined number needed to treat of 2.5 for effectiveness, 3.1 for adverse effects, and 20 for severe effects. For migraine prophylaxis, anticonvulsants had a combined number needed to treat of 1.6 for effectiveness, 2.4 for adverse effects, and 39 for severe effects. Phenytoin had no effect on the irritable bowel syndrome, and carbamazepine had little effect on pain after stroke. Clonazepam was effective in one study for temporomandibular joint dysfunction. No study compared one anticonvulsant with another.

Conclusions: Anticonvulsants were effective for trigeminal neuralgia and diabetic neuropathy and for migraine prophylaxis. Minor adverse effects occurred as often as benefit.

Comment in

  • ACP J Club. 1996 Mar-Apr;124(2):35

Similar articles

  • Anticonvulsant Drugs for Acute and Chronic Pain
    P Wiffen et al. Cochrane Database Syst Rev (2), CD001133. PMID 10796752. - Review
    Although anticonvulsants are used widely in chronic pain surprisingly few trials show analgesic effectiveness. No trial compared different anticonvulsants. There is no ev …
  • WITHDRAWN. Anticonvulsant Drugs for Acute and Chronic Pain
    PJ Wiffen et al. Cochrane Database Syst Rev (1), CD001133. PMID 20091515. - Review
    Although anticonvulsants are used widely in chronic pain surprisingly few trials show analgesic effectiveness. Only one study identified considered cancer pain. There is …
  • Anticonvulsant Drugs for Acute and Chronic Pain
    P Wiffen et al. Cochrane Database Syst Rev (3), CD001133. PMID 16034857. - Review
    Although anticonvulsants are used widely in chronic pain surprisingly few trials show analgesic effectiveness. Only one studied considered cancer pain. There is no eviden …
  • Anticonvulsant Drugs for Acute and Chronic Pain
    P Wiffen et al. Cochrane Database Syst Rev (3), CD001133. PMID 10908487. - Review
    Although anticonvulsants are used widely in chronic pain surprisingly few trials show analgesic effectiveness. No trial compared different anticonvulsants. Only one studi …
  • Carbamazepine for Acute and Chronic Pain
    PJ Wiffen et al. Cochrane Database Syst Rev (3), CD005451. PMID 16034977. - Review
    There is evidence to show that carbamazepine is effective but trials are small.
See all similar articles

Cited by 71 PubMed Central articles

See all "Cited by" articles

References

    1. Diabetologia. 1969 Aug;5(4):215-8 - PubMed
    1. Headache. 1969 Apr;9(1):54-7 - PubMed
    1. Scand J Dent Res. 1970;78(2):144-8 - PubMed
    1. Acta Neurol Scand. 1970;46(4):385-408 - PubMed
    1. N Engl J Med. 1973 Jan 4;288(1):13-6 - PubMed

MeSH terms

Feedback